# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Talis Biomedical shares are trading lower by 49% to $4.58 during Wednesday's session. The company announced board restructu...
-SEC Filing
Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(7.39) per share. This is a 51.22 percent increase over losses of ...
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.